BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 22457233)

  • 1. Feasibility of shutter-speed DCE-MRI for improved prostate cancer detection.
    Li X; Priest RA; Woodward WJ; Tagge IJ; Siddiqui F; Huang W; Rooney WD; Beer TM; Garzotto MG; Springer CS
    Magn Reson Med; 2013 Jan; 69(1):171-8. PubMed ID: 22457233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of prostate DCE-MRI: comparison of fast exchange limit and fast exchange regimen pharmacokinetic models in the discrimination of malignant from normal tissue.
    Lowry M; Zelhof B; Liney GP; Gibbs P; Pickles MD; Turnbull LW
    Invest Radiol; 2009 Sep; 44(9):577-84. PubMed ID: 19668002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discrimination of benign and malignant breast lesions by using shutter-speed dynamic contrast-enhanced MR imaging.
    Huang W; Tudorica LA; Li X; Thakur SB; Chen Y; Morris EA; Tagge IJ; Korenblit ME; Rooney WD; Koutcher JA; Springer CS
    Radiology; 2011 Nov; 261(2):394-403. PubMed ID: 21828189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative sensitivities of DCE-MRI pharmacokinetic parameters to arterial input function (AIF) scaling.
    Li X; Cai Y; Moloney B; Chen Y; Huang W; Woods M; Coakley FV; Rooney WD; Garzotto MG; Springer CS
    J Magn Reson; 2016 Aug; 269():104-112. PubMed ID: 27288764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic contrast-enhanced MRI of prostate cancer at 3 T: a study of pharmacokinetic parameters.
    Ocak I; Bernardo M; Metzger G; Barrett T; Pinto P; Albert PS; Choyke PL
    AJR Am J Roentgenol; 2007 Oct; 189(4):849. PubMed ID: 17885055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DCE-MRI of the prostate using shutter-speed vs. Tofts model for tumor characterization and assessment of aggressiveness.
    Hectors SJ; Besa C; Wagner M; Jajamovich GH; Haines GK; Lewis S; Tewari A; Rastinehad A; Huang W; Taouli B
    J Magn Reson Imaging; 2017 Sep; 46(3):837-849. PubMed ID: 28092414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell membrane water exchange effects in prostate DCE-MRI.
    Li X; Priest RA; Woodward WJ; Siddiqui F; Beer TM; Garzotto MG; Rooney WD; Springer CS
    J Magn Reson; 2012 May; 218():77-85. PubMed ID: 22578558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The magnetic resonance shutter speed discriminates vascular properties of malignant and benign breast tumors in vivo.
    Huang W; Li X; Morris EA; Tudorica LA; Seshan VE; Rooney WD; Tagge I; Wang Y; Xu J; Springer CS
    Proc Natl Acad Sci U S A; 2008 Nov; 105(46):17943-8. PubMed ID: 19004780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shutter-speed dynamic contrast-enhanced MRI: Is it fit for purpose?
    Buckley DL
    Magn Reson Med; 2019 Feb; 81(2):976-988. PubMed ID: 30230007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for shutter-speed variation in CR bolus-tracking studies of human pathology.
    Yankeelov TE; Rooney WD; Huang W; Dyke JP; Li X; Tudorica A; Lee JH; Koutcher JA; Springer CS
    NMR Biomed; 2005 May; 18(3):173-85. PubMed ID: 15578708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate cancer detection on dynamic contrast-enhanced MRI: computer-aided diagnosis versus single perfusion parameter maps.
    Sung YS; Kwon HJ; Park BW; Cho G; Lee CK; Cho KS; Kim JK
    AJR Am J Roentgenol; 2011 Nov; 197(5):1122-9. PubMed ID: 22021504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular-interstitial water exchange and its effect on the determination of contrast agent concentration in vivo: dynamic contrast-enhanced MRI of human internal obturator muscle.
    Buckley DL; Kershaw LE; Stanisz GJ
    Magn Reson Med; 2008 Nov; 60(5):1011-9. PubMed ID: 18956419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiparametric MRI for prostate cancer detection: Preliminary results on quantitative analysis of dynamic contrast enhanced imaging, diffusion-weighted imaging and spectroscopy imaging.
    Fusco R; Sansone M; Petrillo M; Setola SV; Granata V; Botti G; PerdonĂ  S; Borzillo V; Muto P; Petrillo A
    Magn Reson Imaging; 2016 Sep; 34(7):839-45. PubMed ID: 27071309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of arterial spin labeling perfusion MRI and DCE-MRI in human prostate cancer.
    Cai W; Li F; Wang J; Du H; Wang X; Zhang J; Fang J; Jiang X
    NMR Biomed; 2014 Jul; 27(7):817-25. PubMed ID: 24809332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimized Fast Dynamic Contrast-Enhanced Magnetic Resonance Imaging of the Prostate: Effect of Sampling Duration on Pharmacokinetic Parameters.
    Othman AE; Falkner F; Martirosian P; Schraml C; Schwentner C; Nickel D; Nikolaou K; Notohamiprodjo M
    Invest Radiol; 2016 Feb; 51(2):106-12. PubMed ID: 26447494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reproducibility and correlation between quantitative and semiquantitative dynamic and intrinsic susceptibility-weighted MRI parameters in the benign and malignant human prostate.
    Alonzi R; Taylor NJ; Stirling JJ; d'Arcy JA; Collins DJ; Saunders MI; Hoskin PJ; Padhani AR
    J Magn Reson Imaging; 2010 Jul; 32(1):155-64. PubMed ID: 20578023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statistical comparison of dynamic contrast-enhanced MRI pharmacokinetic models in human breast cancer.
    Li X; Welch EB; Chakravarthy AB; Xu L; Arlinghaus LR; Farley J; Mayer IA; Kelley MC; Meszoely IM; Means-Powell J; Abramson VG; Grau AM; Gore JC; Yankeelov TE
    Magn Reson Med; 2012 Jul; 68(1):261-71. PubMed ID: 22127821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. R2* Relaxation Affects Pharmacokinetic Analysis of Dynamic Contrast-Enhanced MRI in Cancer and Underestimates Treatment Response at 7 T.
    Kim J; Moestue SA; Bathen TF; Kim E
    Tomography; 2019 Sep; 5(3):308-319. PubMed ID: 31572792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic parameters from 3-Tesla DCE-MRI as surrogate biomarkers of antitumor effects of bevacizumab plus FOLFIRI in colorectal cancer with liver metastasis.
    Hirashima Y; Yamada Y; Tateishi U; Kato K; Miyake M; Horita Y; Akiyoshi K; Takashima A; Okita N; Takahari D; Nakajima T; Hamaguchi T; Shimada Y; Shirao K
    Int J Cancer; 2012 May; 130(10):2359-65. PubMed ID: 21780098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnostic value of quantitative pharmacokinetic parameters and relative quantitative pharmacokinetic parameters in breast lesions with dynamic contrast-enhanced MRI].
    Sun TT; Liu WH; Zhang YQ; Li LH; Wang R; Ye YY
    Zhonghua Yi Xue Za Zhi; 2017 Aug; 97(29):2266-2270. PubMed ID: 28780840
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.